Actinic Keratosis Market Size Forecasted To Achieve 10.58 Billion By 2029 With Steady Growth

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Actinic Keratosis Market Size and Projected Growth Rate?
The market size for actinic keratosis has seen a consistent rise in the past few years. It is expected to escalate from $7.95 billion in 2024 to $8.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The past growth is due to factors such as increased exposure to UV radiation, an aging demographic, heightened skin cancer awareness, a surge in actinic keratosis prevalence, improved healthcare facilities, growing disposable income, supportive policies from the government, and an increased emphasis on preventative skincare.

The market size for actinic keratosis is anticipated to skyrocket in the upcoming years. By 2029, it is projected to reach $10.58 billion with a Compound Annual Growth Rate (CAGR) of 7.4%. Factors contributing to this growth over the projected period include new therapeutic procedures, improvements in diagnostic tools powered by AI, higher usage of combination treatments, increased demand for non-invasive methods, wider utilization of tele dermatology, a broader scope of photodynamic therapy applications, greater understanding of cosmetic results, the creation of specialized biologic treatments, further healthcare investments in developing markets, and an increased emphasis on early detection and prevention. Throughout the forecast period, significant trends consist of diagnostic tools pushed by AI, machine learning in lesion analysis, advanced systems for photodynamic therapy, wearable devices for uv monitoring, drug delivery using nanotechnology, 3D imaging for personal treatments, portable phototherapy devices for home use, early detection biosensors, lesion classification software that is automated, and hydrogel-based therapeutic systems.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077

What Are the Major Segments in the Actinic Keratosis Market?
The actinic keratosis market covered in this report is segmented -

1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types
2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users

Subsegments:
1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids
2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision
3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy
4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp

What Are The Driving Actinic Keratosis Market Evolution?
Rapidly growing instances of severe sunburn are predicted to facilitate the advancement of the actinic keratosis market. Severe sunburn manifests as an intense skin injury prompted by an overexposure to ultraviolet (UV) rays, leading to symptoms such as redness, pain, swelling, and potential blistering. The cause of sunburns can be attributed to a number of factors, such as extended UV radiation exposure, inadequate sun protection measures, increased outdoor activity during peak UV hours, and the escalation in temperature due to climate change. Actinic keratosis is induced by sunburn when UV radiation damages the skin cell's DNA, causing mutations that disrupt the normal functionality of the cell, leading to the growth of precancerous lesions, particularly amid sustained or prolonged sun exposure. Melanoma Focus, a UK-based charity, reported that in the period between 2022-23, there were 201 hospital admissions due to sunburn, including 89 children and 25 babies under one year old. The charity also discovered that 66% of UK adults aged 16-65 recalled suffering from sunburn as children, 65% of them suffered severe sunburn with blisters at least once. This figure increased to 77% for individuals with fair, pale, or white skin. Consequently, the escalation in severe sunburn cases is fostering the expansion of the actinic keratosis market.

Which Firms Dominate The Actinic Keratosis Market Segments?
Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.

What Trends Are Expected to Dominate the Actinic Keratosis Market in the Next 5 Years?
In the actinic keratosis market, leading businesses are prioritizing the development of topical ointments. Such ointments are expected to efficiently target and eradicate precancerous growths, lower recurrence rates, and enhance patient compliance by offering shorter treatment periods and enhanced safety profiles. These topical ointments, are medicated creams or gels, applied directly to the impacted skin, with active components like tirbanibulin that target abnormal keratinocytes to treat precancerous growths. For example, in June 2024, the US Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for Almirall SA, a biopharmaceutical firm based in Spain, to increase the usage area of its drug, Klisyri, to up to 100 cm2. Klisyri (tirbanibulin) 1% ointment is developed as a microtubule inhibitor to prevent the growth of abnormal keratinocytes, effectively minimizing the quantity and size of precancerous lesions in the treatment of actinic keratosis (AK) on the face or scalp.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report

Which Is The Largest Region In The Actinic Keratosis Market?
North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Actinic Keratosis Market?
2. What is the CAGR expected in the Actinic Keratosis Market?
3. What Are the Key Innovations Transforming the Actinic Keratosis Industry?
4. Which Region Is Leading the Actinic Keratosis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.